|
US20030220234A1
(en)
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
|
US5891845A
(en)
*
|
1997-11-21 |
1999-04-06 |
Fuisz Technologies Ltd. |
Drug delivery systems utilizing liquid crystal structures
|
|
IT1298731B1
(it)
*
|
1998-03-13 |
2000-02-02 |
Recordati Chem Pharm |
Composizioni farmaceutiche contenenti complessi di inclusione con melatonina
|
|
US6241969B1
(en)
*
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
|
US6200550B1
(en)
*
|
1998-12-11 |
2001-03-13 |
Q-Pharma, Inc. |
Oral care compositions comprising coenzyme Q10
|
|
US6045826A
(en)
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US6632443B2
(en)
*
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US20080070981A1
(en)
|
2000-02-23 |
2008-03-20 |
Henryk Borowy-Borowski |
Water-soluble compositions of bioactive lipophilic compounds
|
|
AR025587A1
(es)
|
1999-09-13 |
2002-12-04 |
Hoffmann La Roche |
Formulaciones en dispersion que contienen inhibidores de lipasa
|
|
WO2001039836A1
(en)
*
|
1999-12-01 |
2001-06-07 |
Natco Pharma Limited |
A rapid acting freeze dired oral pharmaceutical composition for treating migraine
|
|
CA2397871A1
(en)
*
|
2000-01-20 |
2001-07-26 |
Supratek Pharma Inc. |
Novel podophyllotoxin compositions
|
|
DE10046541A1
(de)
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
|
AR033711A1
(es)
*
|
2001-05-09 |
2004-01-07 |
Novartis Ag |
Composiciones farmaceuticas
|
|
WO2003033526A2
(en)
|
2001-10-19 |
2003-04-24 |
Isotechnika Inc. |
Synthesis of cyclosporin analogs
|
|
FR2840614B1
(fr)
*
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
|
AU2002350719A1
(en)
|
2002-11-29 |
2004-06-23 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
|
|
WO2004069180A2
(en)
|
2003-01-31 |
2004-08-19 |
Smithkline Beecham Corporation |
Solid dispersion compositions
|
|
JP2006517929A
(ja)
*
|
2003-02-19 |
2006-08-03 |
ハー・ルンドベック・アクチエゼルスカベット |
溶融アグロメレーションを用いてアグロメレートを製造する方法
|
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
|
WO2005058290A2
(en)
*
|
2003-12-18 |
2005-06-30 |
Dsm Ip Assets B.V. |
Vitamin e for facilitating the synchronization of circadian rhythm
|
|
WO2006036614A2
(en)
*
|
2004-09-24 |
2006-04-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer
|
|
WO2006039268A2
(en)
*
|
2004-09-30 |
2006-04-13 |
Eastman Chemical Company |
Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
|
|
US20060088591A1
(en)
*
|
2004-10-22 |
2006-04-27 |
Jinghua Yuan |
Tablets from a poorly compressible substance
|
|
US7446096B2
(en)
*
|
2005-12-19 |
2008-11-04 |
Industrial Technology Research Institute |
Glutathione based delivery system
|
|
US8067380B2
(en)
|
2005-12-19 |
2011-11-29 |
Industrial Technology Research Institute |
Glutathione-based delivery system
|
|
WO2008007728A1
(fr)
*
|
2006-07-13 |
2008-01-17 |
Kaneka Corporation |
Préparation orale contenue dans une structure à membrane lipidique, et agent contre la fatigue comprenant une coenzyme comme ingrédient actif
|
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
AU2009224418B2
(en)
*
|
2008-03-11 |
2014-12-11 |
Aska Pharmaceutical Co., Ltd. |
Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
|
|
EP2548456B1
(en)
*
|
2008-03-20 |
2015-07-08 |
Virun, Inc. |
Emulsions including a PEG-derivative of tocopherol
|
|
MX2010010214A
(es)
*
|
2008-03-20 |
2010-12-21 |
Virun Inc |
Derivados de vitamina e y sus usos.
|
|
AR075180A1
(es)
*
|
2009-01-29 |
2011-03-16 |
Novartis Ag |
Formulaciones orales solidas de una pirido-pirimidinona
|
|
WO2010092925A1
(ja)
*
|
2009-02-12 |
2010-08-19 |
あすか製薬株式会社 |
固体分散体とその医薬組成物、並びにそれらの製造方法
|
|
US8252821B2
(en)
*
|
2009-04-14 |
2012-08-28 |
Bristol-Myers Squibb Company |
Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
|
|
CA2792330C
(en)
|
2010-03-23 |
2017-01-03 |
Virun, Inc |
Nanoemulsion including a peg-derivative of vitamin e and a sucrose fatty acid ester
|
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
ITMI20112042A1
(it)
*
|
2011-11-10 |
2013-05-11 |
Eratech S R L |
Polvere da ricostituire prima dell'uso comprendente melatonina e preparazione iniettabile ottenibile da tale polvere.
|
|
ITRM20120331A1
(it)
|
2012-07-12 |
2014-01-13 |
Guidotti & C Spa Labor |
Composizioni pediatriche orali liquide contenenti nepadutant.
|
|
FR2999081B1
(fr)
*
|
2012-12-06 |
2015-02-27 |
Hra Pharma Lab |
Dispersion solide d'un modulateur selectif du recepteur a la progesterone
|
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
|
HUP1300647A2
(hu)
*
|
2013-11-12 |
2015-05-28 |
Druggability Technologies Ip Holdco Jersey Ltd |
Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
|
|
US11331279B2
(en)
|
2014-05-29 |
2022-05-17 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
US12544389B2
(en)
|
2014-05-29 |
2026-02-10 |
Fresh Cut Development, Llc |
Stable cannabinoid formulations
|
|
US11911361B2
(en)
|
2014-05-29 |
2024-02-27 |
Radius Pharmaceuticals, Inc. |
Stable cannabinoid formulations
|
|
GB201410869D0
(en)
*
|
2014-06-18 |
2014-07-30 |
Perioc Ltd |
Novel pharmaceutical formulations and their use in the treatment of periodontal disease
|
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
|
ES2938560T5
(en)
*
|
2015-05-28 |
2026-04-24 |
Fresh Cut Dev Llc |
Stable cannabinoid formulations
|
|
EA201892396A1
(ru)
|
2016-12-02 |
2019-04-30 |
Ресептор Лайф Сайенсиз, Инк. |
Быстродействующие растительные лекарственные соединения и биологически активные добавки
|
|
EP3565539A4
(en)
*
|
2017-01-03 |
2020-08-12 |
Receptor Holdings, Inc. |
MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
|
|
CN110636834A
(zh)
*
|
2017-02-15 |
2019-12-31 |
分子浸剂有限公司 |
制剂
|
|
CN108245683B
(zh)
*
|
2018-01-26 |
2020-02-14 |
华中科技大学 |
一种具有p-糖蛋白抑制功能的抗肿瘤前药及制备方法
|
|
UY38480A
(es)
|
2018-11-19 |
2020-06-30 |
Receptor Holdings Inc |
Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides
|
|
JP7675724B2
(ja)
*
|
2019-12-20 |
2025-05-13 |
インターベット インターナショナル ベー． フェー． |
ピラゾール医薬組成物
|
|
TW202128158A
(zh)
*
|
2019-12-20 |
2021-08-01 |
瑞士商愛杜西亞製藥有限公司 |
包含n-[1-(5-氰基-吡啶-2-基甲基)-1h-吡唑-3-基]-2-[4-(1-三氟甲基-環丙基)-苯基]-乙醯胺之醫藥組合物
|
|
EP4121057A1
(en)
*
|
2020-03-19 |
2023-01-25 |
AC Immune SA |
Dose treatments of tauopathies
|
|
IT202200002528A1
(it)
*
|
2022-02-11 |
2023-08-11 |
Pierpaoli Exelyas S R L |
Composizione comprendente melatonina ad alta biodisponibilità
|